Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Whitestone REIT Files Definitive Proxy Materials and Mails Letter to Shareholders
-
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
-
Man Group PLC : Form 8.3 - Tritax Big Box REIT plc
-
VTech Completes Acquisition of Assets of Gigaset Communications GmbH
-
Man Group PLC : Form 8.3 - Smith (DS) plc
-
Notice of AGM
-
Man Group PLC : Form 8.3 - International Paper Company
-
Lectra: Monthly declaration of the total number of shares and voting rights composing the company's capital (at March 31th, 2024)
-
Chakana Commences Drill Program to Test Mega-Gold, La Joya, and Estremadoyro - Soledad Project, Peru
-
Man Group PLC : Form 8.3 - Mondi plc
-
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
-
Ancora Issues Letter to Fellow Shareholders Regarding Norfolk Southern’s Failures of Diligence and Poor Judgment in Appointing John Orr as COO
-
Form 8.3 - Tritax Big Box Reit Plc
-
Orion Undertakes A$593 Million Sale of Capstone CDIs on the ASX
-
Form 8.3 - Mattioli Woods
-
Bill Savings Program For Non-Profits To Enhance Cash Flow Management Launched
-
Honey Badger Silver Provides Update On Non-Brokered Private Placement
-
MONSTER ENERGY BACK AS THE OFFICIAL ENERGY DRINK OF THE BIG3
-
Theralase(R) Granted Canadian Cancer Vaccine Patent
-
ADU Industry Leader CCS Offers a Cost-Effective Way to Expand Space and Capacity in Care and Rehab Facilities Without Buying a New Property
-
Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410—a Modifier Gene Therapy—in Phase 1/2 ArMaDa Study for Geographic Atrophy
-
Clough Global Opportunities Fund Declares Monthly Cash Distributions For April, May and June 2024 of $0.0480 Per Share
-
Clough Global Equity Fund Declares Monthly Cash Distributions For April, May And June 2024 Of $0.0603 Per Share
-
Happy Belly's Yolks Breakfast Signs Five-Unit Franchise Agreement in Ontario
-
Clough Global Dividend and Income Fund Declares Monthly Cash Distributions for April, May and June 2024 of $0.0526 Per Share
-
IAMGOLD Provides Notice of First Quarter 2024 Results and Conference Call
-
Kiora Pharmaceuticals to Present at Upcoming Investor Conferences
-
Reaves Utility Income Fund Announces Regular Monthly Distributions of $0.19 per Share
-
Stellantis 2023 Corporate Social Responsibility Report Outlines Strong Results Against Ambitious Dare Forward 2030 Targets
-
Form 8.3 - AXA INVESTMENT MANAGERS: SPIRENT COMMUNICATIONS PLC
-
Through the Municipal DIF Office, Sunset World Group Joins the Blue Heart Campaign for the Prevention of Human Trafficking
-
US Housing Market 1Q 2024
-
The Alzheimer's Association® and Rippl Partner to Improve Quality Dementia Care and Caregiver Support
-
BPGbio Presents Key Advances in its Oncology Pipeline related to the NAi Interrogative Biology Platform
-
Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research
-
The Law Offices of Steven H. Heisler Offers Legal Representation for Those Businesses and Union Workers Economically Harmed by Francis Scott Key Bridge Collapse
-
Cielo Announces Closing of Second Tranche of Private Placement of Convertible Debenture Units
-
IMFINZI® (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial
-
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meetin
-
Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today
-
Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer
-
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference
-
Nucleai Unveils Breakthrough AI Spatial Biomarker Advancements at AACR 2024 with the Potential to Transform Cancer Diagnostics and Treatments
-
FeedbackHR.com - The Quantum Leap in Employee Feedback Analysis
-
HERITAGE Opens San Diego Production Facility
-
Edgescan Releases 2024 Vulnerability Statistics Report
-
Upbound Group, Inc. Announces New Independent Director Molly Langenstein
-
CI Financial Corp. Announces Final Results of Substantial Issuer Bid
